It’s a unique and troubling time. We are all of course concerned about the coronavirus and its disruption to our personal and professional lives.
I presume that life will return to normal later this year. But what happens then? Will there be long-term changes to how the drug channel operates? Will we see permanent changes in behavior, policy, and industry structure?
To answer these questions, I want to tap the collective insights of Drug Channels’ 30,000+ audience.
This survey should take 10 minutes or less. I will provide a full review of the results next week on Drug Channels.
You can respond anonymously. Any information you provide will be kept confidential. Per Drug Channels’ long-standing policy, I never publish, release, or disclose any personal data without your permission.
Thanks in advance for sharing your insights.
Regards,
Adam
Source: Post feed
